Mucosal Immune Response Flashcards

You may prefer our related Brainscape-certified flashcards:
2
Q

important components of the mucosal barrier

A

gastric acid, pancreatic enzymes, bile acids, peristalsis, biofilm, secreted IgA and defensins, TIGHT JUNCTIONS (like a “force field” to prevent bacteria from coming in contact with immune cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

where are most of the immune cells in the gut?

A

lamina propia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

sequence of steps in mucosal defense to an invasive microbe

A

serum/mucosal factors (complement, Ig, antimicrobial peptides) ? neutrophils ? acute inflamm., macrophages ? lymphocyte response, clearance of pathogens, and resoration of homeostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does the gut sample the lumen contents?

A

M (microfold) cells that constantly “taste” bits of lumen; no mucos, no villi, selective uptake of antigen only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

lifecycle of an intestinal lymphocyte

A

born in bone marrow/thymus, migrates to Peyer’s patches where activated, expansion in MLN, homing back to intestinal lamina propia at sight of original matching antigen, but also to other mucosal surfaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

preferential migration to mucosal sites results from?

A

expression of unique complementary adhesion molecules (by mucosal lymphocytes) and addressins (by endotherlial cells) basically tags the lymphocyte to migrate to mucosal epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

lymphocytes express this unique complementary adhesion molecule

A

a4-b7 integrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

mucosal endothelium expresses this addressin cell adhesion molecule

A

MAdCAM-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

secretory IgA

A

most abundant Ig in the human body; prevents attachment and invasion of pathogenic bacteria by dimerizing with J chain and transcytosing across mucosal epithelial cells, where it blocks colonization and uptake of bacteria in the gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

oral tolerance

A

antigen feeding induces tolerance to subsequent systemic antigen immunization – why we don’t have an immune response to everything we eat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TH3

A

stimulated by dietary luminal antigen, suppresses immune response by release of TGFb and IL-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tr1

A

stimulated by bacteria in the luminal antigen, supresses immune response by release by IL-10, TGFb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

There are also CD8 cells in the intestine that suppress by release of?

A

TGFb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

intestinal macrophages have these unique functional adaptations

A

release much fewer cytokines, do not express traditional surface molecules that activate immune response, “inflammation anergic” (still phagocytose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

a defective innate immunity or decreased mucosal barrier function results in?

A

prolonged mucosal microbial exposure, T cell responses (Crohn’s ds)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

a lack of oral tolerance results in?

A

chronic inflammation (Crohn’s ds, ulcerative colitis, celiac ds)

18
Q

ulcerative colitis

A

diffuse inflamm of mucosa of colon, TH2 mediated

19
Q

Crohn’s disease

A

segmental inflamm of any part of GI tract, TH1/17 mediated (see nodularity, ulceration, narrowing)

20
Q

Crohn’s disease pathogenesis is a complex interplay between?

A

microbiota, environmental triggers, immune response, and genetic susceptibility

21
Q

we have engineered anti-____ monoclonal antibodies to decrease inflammatory response in Crohn’s disease

A

anti-TNF (infliximab), anti-IL-12/23 (Ustekinumab), anti-alpha4 (Natalizumab)

22
Q

What happened to patients on anti-alpha4 (natalizumab)? What was it replaced with?

A

acquired PML; anti-a4b7, antib7, antiMAdCAM